ABCL icon

AbCellera Biologics

126 hedge funds and large institutions have $368M invested in AbCellera Biologics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 44 reducing their positions, and 18 closing their positions.

Holders
126
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
35
Reduced
44
Closed
18
Calls
$2.39M
Puts
$1.01M
Net Calls
+$1.39M
Net Calls Change
+$1.63M
Name Market Value Shares Shares
Change
Shares
Change %
National Bank of Canada
126
National Bank of Canada
Quebec, Canada
$331 106 -3,127 -97%
VOYA Investment Management
127
VOYA Investment Management
Georgia
-10,624,185 Closed
PM
128
Prosight Management
Texas
-2,815,652 Closed
PP
129
PDT Partners
New York
-64,304 Closed
JG
130
Jain Global
New York
-54,918 Closed
CC
131
Centiva Capital
New York
-46,621 Closed
OAM
132
Oxford Asset Management
United Kingdom
-28,241 Closed
Allianz Asset Management
133
Allianz Asset Management
Germany
-25,622 Closed
CCP
134
Clarkston Capital Partners
Michigan
-22,000 Closed
QCG
135
Quadrant Capital Group
Ohio
-21,946 Closed
IWM
136
IMG Wealth Management
Florida
-19,000 Closed
SP
137
SIH Partners
Delaware
-17,163 Closed
AIA
138
AssuredPartners Investment Advisors
Florida
-15,356 Closed
QC
139
Quadrature Capital
United Kingdom
-14,584 Closed
SWA
140
Stratos Wealth Advisors
Ohio
-12,000 Closed
ECM
141
Evergreen Capital Management
Washington
-11,633 Closed
Mariner
142
Mariner
Kansas
-10,966 Closed
RhumbLine Advisers
143
RhumbLine Advisers
Massachusetts
-135 Closed
CA
144
Continuum Advisory
Idaho
-93 Closed
CM
145
Caption Management
Oklahoma
Simplex Trading
146
Simplex Trading
Illinois